Influenza :: FDA Advisory Committee Recommends Expanded Use of FluMist

MedImmune, Inc. (Nasdaq: MEDI) announced that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted in favor of expanding the population for use of FluMist (Influenza Virus Vaccine Live, Intranasal) to include children under 5 years of age.

Hair Loss :: Follica developing breakthrough discovery to treat hair loss

Technology licensed by Follica Inc. from the University of Pennsylvania School of Medicine has been used to generate completely new hair follicles for the first time in normal adult mammals. The paper describing the experiment was published in the May 17th issue of the scientific journal Nature.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack